545 related articles for article (PubMed ID: 10430026)
1. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer by adeno-associated virus vectors into the central nervous system.
Xiao X; Li J; McCown TJ; Samulski RJ
Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
4. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
5. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
Allen JM; Halbert CL; Miller AD
Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
[TBL] [Abstract][Full Text] [Related]
6. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
7. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
8. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
Dunbar CE; Emmons RV
Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
[TBL] [Abstract][Full Text] [Related]
10. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus-mediated gene delivery.
Snyder RO
J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
[TBL] [Abstract][Full Text] [Related]
13. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
14. Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene.
Peng L; Sidner RA; Bochan MR; Burton MM; Cooper ST; Jindal RM
J Surg Res; 1997 Apr; 69(1):193-8. PubMed ID: 9202669
[TBL] [Abstract][Full Text] [Related]
15. AAV vectors for hemophilia B gene therapy.
Chao H; Walsh CE
Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
[TBL] [Abstract][Full Text] [Related]
16. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
17. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
[TBL] [Abstract][Full Text] [Related]
18. [Gene transfer using adeno-associated virus (AAV) vectors].
Shimada T
Nihon Rinsho; 1997 Aug; 55(8):2156-9. PubMed ID: 9284438
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
20. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]